Results 181 to 190 of about 10,401 (200)

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma

Allergy: European Journal of Allergy and Clinical Immunology, 2020
Ioana Agache, Cezmi A Akdis, Mubeccel Akdis   +2 more
exaly  

Mepolizumab

Reactions Weekly, 2010
openaire   +1 more source

Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trial

Gut, 2023
Evan Dellon, Ikuo Hirano
exaly  

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

Lancet, The, 2012
Ian D Pavord, Peter Howarth, Oliver N Keene   +2 more
exaly  

Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial

Lancet Respiratory Medicine,the, 2017
Frank C Albers, Linda M Nelsen, Jennifer L Trevor   +2 more
exaly  

Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial

Lancet, The, 2022
exaly  

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies

Lancet Respiratory Medicine,the, 2016
Steven W Yancey, Oliver N Keene, Eugene R Bleecker   +2 more
exaly  

Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial

Gut, 2010
Hirohito Kita, H-U Simon
exaly  

Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

New England Journal of Medicine, 2014
Ian D Pavord, Guy G Brusselle, Alfredo Chetta   +2 more
exaly  

Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma

New England Journal of Medicine, 2014
Sally E Wenzel, Oliver N Keene, Steven W Yancey   +2 more
exaly